Abstract:Many agents targeting the colchicine binding site in tubulin have been developed as potential anticancer agents. However, none has successfully made it to the clinic, due mainly to dose limiting toxicities and the emergence of multi-drug resistance. Chalcones targeting tubulin have been proposed as a safe and effective alternative. We have shown previously that quinolone chalcones target tubulin and maintain potent anti-proliferative activity vis-à-vis colchicine, while also having high tolerability and low toxicity in mouse models of cancer and refractivity to multi-drug resistance mechanisms. To identify the most effective anticancer chalcone compound, we synthesized 17 quinolone-chalcone derivatives based on our previously published CTR-17 and CTR-20, and then carried out a structure-activity relationship study. We identified two compounds, CTR-21 [((E)-8-Methoxy-3-(3-(2-methoxyphenyl)-3-oxoprop-1-enyl) quinolin-2(1H)-one)] and CTR-32 [((E)-3-(3-(2-ethoxyphenyl)-3-oxoprop-1-enyl) quinolin-2(1H)-one)] as potential leads, which contain independent moieties that play a significant role in their enhanced activities. At the nM range, CTR-21 and CTR-32 effectively kill a panel of different cancer cells originated from a variety of different tissues including breast and skin. Both compounds also effectively kill multi-drug resistant cancer cells. Most importantly, CTR-21 and CTR-32 show a high degree of selectivity against cancer cells. In silico, both of them dock near the colchicine-binding site with similar energies. Whereas both CTR-21 and CTR-32 effectively prevents tubulin polymerization, leading to the cell cycle arrest at G2/M, CTR-21 has more favorable metabolic properties. Perhaps not surprisingly, the combination of CTR-21 and ABT-737, a Bcl-2 inhibitor, showed synergistic effect in killing cancer cells, since we previously found the "parental" CTR-20 also exhibited synergism. Taken together, CTR-21 can potentially be a highly effective and relatively safe anticancer drug.

Synthesis, Evaluation, and Mechanism Study of Novel Indole-Chalcone Derivatives Exerting Effective Antitumor Activity Through Microtubule Destabilization in Vitro and in Vivo

Synthesis and biological evaluation of novel chalcone derivatives as a new class of microtubule destabilizing agents.

Discovery of Novel Quinoline-Chalcone Derivatives As Potent Antitumor Agents with Microtubule Polymerization Inhibitory Activity.

Synthesis, biological evaluation and mechanism study of chalcone analogues as novel anti-cancer agents

Design, Synthesis and Biological Evaluation of a Series of Pyrano Chalcone Derivatives Containing Indole Moiety As Novel Anti-Tubulin Agents.

Synthesis, Anticancer Activity and Molecular Modeling Studies of Novel Chalcone Derivatives Containing Indole and Naphthalene Moieties As Tubulin Polymerization Inhibitors.

Design, Synthesis and Biological Evaluation of Pyridine-Chalcone Derivatives As Novel Microtubule-Destabilizing Agents

Synthesis and Biological Evaluation of Novel Pyranochalcone Derivatives As A New Class of Microtubule Stabilizing Agents

Lead optimization of novel quinolone chalcone compounds by a structure-activity relationship (SAR) study to increase efficacy and metabolic stability

Design, Synthesis and Biological Evaluation of 9-Aryl-5h-pyrido[4,3-b]indole Derivatives As Potential Tubulin Polymerization Inhibitors.

Design, Synthesis, and Biological Evaluation of 4-Aryl-9h-carbazoles As Tubulin Polymerization Inhibitors with Potent Anticancer Activities

Design, Synthesis and Biological Evaluation of Novel 2-Phenyl-4,5,6,7-tetrahydro-1h-indole Derivatives As Potential Anticancer Agents and Tubulin Polymerization Inhibitors

Design, Synthesis, and Biological Evaluation of Chalcone‐Containing Shikonin Derivatives As Inhibitors of Tubulin Polymerization

Design, synthesis, and biological evaluation of novel diphenylamine derivatives as tubulin polymerization inhibitors targeting the colchicine binding site

Design, Synthesis, and Biological Evaluation of Cyclic-Indole Derivatives As Anti-Tumor Agents Via the Inhibition of Tubulin Polymerization.

Synthesis, Molecular Properties Prediction and Biological Evaluation of Indole-Vinyl Sulfone Derivatives As Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site.

Design, synthesis and biological evaluation of vinyl selenone derivatives as novel microtubule polymerization inhibitors

Design, synthesis, biological evaluation and molecular docking studies of new chalcone derivatives containing diaryl ether moiety as potential anticancer agents and tubulin polymerization inhibitors.

Design, synthesis, and biological evaluation of 4-aryl-9 H -carbazoles as tubulin polymerization inhibitors with potent anticancer activities

Design, Synthesis and Biological Evaluation of Resveratrol-Cinnamoyl Derivates As Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site.

Design, Synthesis and Biological Evaluation of Novel Dihydroquinolin-4(1H)-one Derivatives As Novel Tubulin Polymerization Inhibitors